Hematologic and cytogenetic responses in dasatinib trials.
| Stage of disease . | No of patients . | CHR, % . | MCyR, % . | CCyR, % . |
|---|---|---|---|---|
| Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response. | ||||
| Chronic phase16 | 186 | 90 | 52 | 39 |
| Accelerated phase17 | 107 | 39 | 33 | 24 |
| Myeloid blast crisis18 | 74 | 26 | 31 | 27 |
| Lymphoid blast crisis18 | 42 | 26 | 50 | 43 |
| Stage of disease . | No of patients . | CHR, % . | MCyR, % . | CCyR, % . |
|---|---|---|---|---|
| Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response. | ||||
| Chronic phase16 | 186 | 90 | 52 | 39 |
| Accelerated phase17 | 107 | 39 | 33 | 24 |
| Myeloid blast crisis18 | 74 | 26 | 31 | 27 |
| Lymphoid blast crisis18 | 42 | 26 | 50 | 43 |